Concepedia

Gil Redelman‐Sidi

GR

15

Publications

1.9K

Citations

15

H-Index

2010

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Kettering University

Parker Institute for Cancer Immunotherapy

Weill Cornell Medicine

Gil Redelman‐Sidi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2010–2025

15

Publications

15

Determinants of COVID-19 disease severity in patients with cancer

Elizabeth Robilotti, N. Esther Babady, Peter A. Mead et al. · Nature Medicine · 2020 · 623 citations · Full text

The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello et al. · Clinical Infectious Diseases · 2016 · 279 citations · Full text

, , +16

Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

Tilly Varughese, Ying Taur, Nina Cohen et al. · Clinical Infectious Diseases · 2018 · 259 citations · Full text

Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways

Richa Gupta, Daniel Barkan, Gil Redelman‐Sidi et al. · Molecular Microbiology · 2010 · 114 citations · Full text

, , +10

Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

Gil Redelman‐Sidi, Gopa Iyer, David B. Solit et al. · Cancer Research · 2013 · 111 citations · Full text

Rows per page

1–5 of 15